Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 238 results for "fda centre for drug evaluation and re..."

New Summary: Cirrhosis in over 16s: assessment and management....

FDA Warning/Regulatory Alert Note from the National Guideline Clearinghouse : This guideline references a drug(s) for which important revised regulatory and/or warning information has been released. May 12, 2016 Fluoroquinolone antibacterial ... National Guideline Clearinghouse, 2 weeks ago

10 images for fda centre for drug evaluation and research

Drug Store News, 2 weeks ago
Minyanville, 1 month ago
Freshnews.com, 1 month ago
CNN, 1 month ago
Nutritional Outlook, 4 months ago
MassDevice, 4 months ago
FOXNews.com, 4 months ago
diaTribe, 4 months ago
MassDevice, 5 months ago
Drug Store News, 6 months ago

Tetra to research pot-based pain drug with Que. clinic

TETRA BIOPHARMA ANNOUNCES IT HAS ENTERED INTO A CLINICAL RESEARCH PARTNERSHIP WITH SANTE CANNABIS, QUEBEC'S LEADING MEDICAL CANNABIS INSTITUTION PhytoPain Pharma Inc. (PPP), a subsidiary of Tetra Bio Pharma Inc., has entered into a clinical ...
 Stockwatch1 day ago Tetra BioPharma Announces it Has Entered into a Clinical Research Partnership with Sante Cannabis, Quebec's Leading Medical Cannabis Institution  4 Traders1 day ago Tetra BioPharma Enters Clinical Research Partnership with Sante Cannabis  Uranium Investing News1 day ago
[x]  
Federal Register

International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs; World Health Organization; Scheduling Recommendations; 4-Methylethcathinone and Nine Other Substances; Request for Comments

Start Preamble Food and Drug Administration, HHS. Notice. The Food and Drug Administration (FDA) is providing interested persons with the opportunity to submit written comments, and to request an informal public meeting concerning ...
 Federal Register1 week ago

1/6/17 - State College company receives FDA approval for cancer therapy trials [Centre Daily Times (State College, Pa.)]

Jan. 06A State College company has taken another step in the fight against cancer. Biopharmaceutical outfit Keystone Nano is testing a way to deliver a cancer-killing lipid, the company announced Wednesday, and received U.S. Food and Drug ...
 Pharmacy Choice2 weeks ago

Unpublished research calls into question efficacy of common morning sickness drug

IMAGE: Previously unpublished research calls into question the efficacy of the most commonly prescribed medication for nausea in pregnancy. Information from the 1970s trial was published today in PLOS ONE by... view more Credit: Courtesy of St.
 EurekAlert!2 weeks ago Previously unpublished research calls into question efficacy of most commonly prescribed medication for nausea in pregnancy  Health Canal2 weeks ago

FDA approves first drug for spinal muscular atrophy

Spinraza improved motor function in SMA patients. The FDA has approved Biogen's Spinraza (nusinersen) under Priority Review for the treatment of spinal muscular atrophy (SMA) in pediatric and adult patients. Spinraza is the first and only ...
 CPhI.cn3 weeks ago

FDA extends review of application for OCREVUS? (ocrelizumab)

Basel Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date for its review of the Biologics Licence Application (BLA) of OCREVUS(TM) ...
 Pharmacy Choice1 month ago

Cubresa SPECT Scanner Used for Evaluation of Alzheimer's Disease Molecular Label in vivo November 22, 2016Cubresa's SPECT scanner was used in a study by Dalhousie University and Mount Saint Vincent University to determine if a...

Wild-Type and 5XFAD Alzheimer's disease (AD) model brains revealing elevation of BChE in AD. SPECT imaging has provided us the first direct in vivo evidence that the TRV6001 label can cross the blood-brain barrier -- lead author Drew DeBay ...
 PRWeb2 months ago
PharmaVOICE

Helix Biopharma Accelerates Escalation Of L-DOS47 Dosing In The U.S. Phase I Study

) - Helix BioPharma Corp. (TSX: HBP ) (FRANKFURT: HBP), a clinical stage immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that after reviewing safety data from the Phase ...
 BioSpace1 month ago Helix BioPharma Corp. Accelerates Escalation of L-DOS47 Dosing in the U.S. Phase I Study  Yahoo! Canada1 month ago Helix BioPharma Corp. : Accelerates Escalation of L-DOS47 Dosing in the U.S. Phase I Study  4 Traders1 month ago
[x]  

The European Lead Factory: A Blueprint for PublicPrivate Partnerships in Early Drug Discovery

Introduction While we continuously obtain a better understanding of disease-causing mechanisms, we still face a number of challenges when translating these findings into therapeutic products that reach patients needs ( 1 , 2 ). Innovation and ...
 Frontiers in Neurorobotics5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less